We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+0.37%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.8B
AUM Growth
-$20.8M
Cap. Flow
+$57.1M
Cap. Flow %
3.18%
Top 10 Hldgs %
23.87%
Holding
255
New
12
Increased
107
Reduced
96
Closed
12

Top Buys

Rank Stock Value
1
GDDY icon
GoDaddy
GDDY
+$28M
2
UPWK icon
Upwork
UPWK
+$20.6M
3
G icon
Genpact
G
+$18.4M
4
FOUR icon
Shift4
FOUR
+$10.2M
5
SRAD icon
Sportradar
SRAD
+$8.21M

Sector Composition

Rank Sector Weight
1 Healthcare 31.73%
2 Technology 29.93%
3 Industrials 16.4%
4 Consumer Discretionary 7.95%
5 Communication Services 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLND icon
176
Blend Labs
BLND
$429M
$1.71M 0.1%
1,006,289
+123,699
+14% +$264K
SMID icon
177
Smith-Midland
SMID
$161M
$1.67M 0.09%
51,346
+756
+1% +$26.1K
CLB icon
178
Core Laboratories
CLB
$511M
$1.66M 0.09%
99,096
-197
-0.2% -$3.52K
NGS icon
179
Natural Gas Services Group
NGS
$450M
$1.64M 0.09%
43,568
-635
-1% -$23.2K
AMSC icon
180
American Superconductor
AMSC
$1.36B
$1.59M 0.09%
47,114
ALG icon
181
Alamo Group
ALG
$2.02B
$1.53M 0.09%
9,292
-19
-0.2% -$3.58K
BWXT icon
182
BWX Technologies
BWXT
$15.3B
$1.51M 0.08%
7,389
-610
-8% -$124K
ON icon
183
ON Semiconductor
ON
$33B
$1.49M 0.08%
24,005
-602
-2% -$37.8K
LLY icon
184
Eli Lilly
LLY
$1.09T
$1.49M 0.08%
1,615
-75
-4% -$76K
JOUT icon
185
Johnson Outdoors
JOUT
$502M
$1.48M 0.08%
31,818
FWRG icon
186
First Watch Restaurant Group
FWRG
$803M
$1.47M 0.08%
139,855
+5,256
+4% +$75.9K
XERS icon
187
Xeris Biopharma Holdings
XERS
$1.41B
$1.46M 0.08%
+251,066
New +$1.66M
CW icon
188
Curtiss-Wright
CW
$26.4B
$1.4M 0.08%
2,053
-247
-11% -$164K
TNDM icon
189
Tandem Diabetes Care
TNDM
$1.2B
$1.4M 0.08%
72,878
+10,463
+17% +$227K
USPH icon
190
US Physical Therapy
USPH
$1.2B
$1.34M 0.07%
17,905
-63
-0.4% -$5.16K
TRS icon
191
TriMas Corp
TRS
$1.45B
$1.3M 0.07%
36,136
-64,756
-64% -$2.32M
MLAB icon
192
Mesa Laboratories
MLAB
$544M
$1.26M 0.07%
14,222
+5
+0% +$431
ERII icon
193
Energy Recovery
ERII
$435M
$1.21M 0.07%
120,522
-1,476
-1% -$19.3K
DOV icon
194
Dover
DOV
$27.5B
$1.21M 0.07%
5,790
-62
-1% -$13.3K
SLP icon
195
Simulations Plus
SLP
$371M
$1.2M 0.07%
101,598
+31,413
+45% +$463K
BRK.B icon
196
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.17M 0.07%
2,450
VMC icon
197
Vulcan Materials
VMC
$37.2B
$1.17M 0.07%
4,299
-55
-1% -$16.2K
WOOF icon
198
Petco
WOOF
$791M
$1.16M 0.06%
417,423
-939
-0.2% -$2.6K
XYL icon
199
Xylem
XYL
$29.8B
$1.15M 0.06%
9,632
-127
-1% -$16.7K
ABBV icon
200
AbbVie
ABBV
$468B
$1.13M 0.06%
5,209
-120
-2% -$26.6K

Similar funds

Rice Hall James & Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Rice Hall James & Associates held 255 positions worth $1.8B, down 1.1% from $1.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates deployed $57.1M of net new capital in Q1 2026, opening 12 new positions and adding to 107 existing holdings. Its largest new stake was Upwork: 1,308,167 shares worth $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Amicus Therapeutics, an estimated $39.3M trimmed.

  • Rice Hall James & Associates's largest Q1 2026 buy was Upwork: 1,308,167 shares worth $14.3M.
  • Rice Hall James & Associates added most to GoDaddy in Q1 2026, an estimated $28M increase.
  • Rice Hall James & Associates's biggest Q1 2026 reduction was Amicus Therapeutics, cutting an estimated $39.3M.
  • Rice Hall James & Associates fully exited iShares Micro-Cap ETF in Q1 2026, selling an estimated $4.53M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.8B portfolio in Q1 2026.
  • Rice Hall James & Associates opened 12 new positions and closed 12 in Q1 2026.
  • Rice Hall James & Associates's portfolio value fell 1.1% quarter-over-quarter to $1.8B.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.